ETC’s medicinal chemistry team is involved in the generation of novel drug molecules with proprietary intellectual property and freedom-to-operate rights. The design of new molecules is supported by capabilities in molecular modelling as well as molecular dynamics calculations and protein crystallography. In addition, the group has expertise in the synthesis of peptides for use as therapeutics, reagents and diagnostics.